Video

Dr. Choti on the Role of Surgery in Rectal Cancer

Michael A. Choti, MD, chief of surgery, Banner MD Anderson Cancer Center, discusses the role of surgery in the treatment of patients with rectal cancer.

Michael A. Choti, MD, chief of surgery, Banner MD Anderson Cancer Center, discusses the role of surgery in the treatment of patients with rectal cancer.

Surgery is very important, says Choti, and to achieve the best outcome the procedure generally involves full removal of the rectal lymph node. Neoadjuvant therapy can sometimes make the surgery easier. Through chemotherapy or radiotherapy, shrinking the tumor preoperatively can lead to sphincter-preserving surgery so that a permanent colostomy will not be required. Patients who typically have the best outcomes are the ones with low tumors located near the anus.

Choti adds that new surgical techniques using robotics are changing the treatment landscape. Total mesorectal excision can now be performed more effectively, leading to a better reconstructive result in the adjuvant setting.

Related Videos
Dr Dorritie on the Clinical Implications of the 5-Year Follow-Up Data From CAPTIVATE in CLL/SLL
Minoo Battiwalla, MD, MS
Kathleen N. Moore, MD, MS
Paolo Caimi, MD
Dr Oveisi on the Importance of Patient Counseling Prior to CAR T-Cell Therapy in Myeloma
Leo I. Gordon, MD
Janaki Neela Sharma, MD, University of Miami
Richard Kim, MD, Moffitt Cancer Center
Janaki Neela Sharma, MD, discusses CheckMate 901, and where nivolumab plus chemotherapy fits into the advanced urothelial cancer treatment paradigm.
David Rimm, MD, PhD, discusses current HER2 immunohistochemistry assays that are used in the management of breast cancer, and their shortcomings.